The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
MM+M Podcast 1.25.22: Overseeing comms for the firm that launched Moderna
Christine Heenan, Flagship Pioneering’s CCO, explains how she addressed scrutiny over Flagship’s hiring of former FDA commissioner Stephen Hahn, her take on the CDC’s messaging challenges, and more.
MM+M Podcast 1.18.22: Digital health’s funding frenzy (and what it means)
Sari Kaganoff, head of consulting for Rock Health, unpacks the numbers and interprets the directional signs behind last year’s frenzied funding environment for digital health, including how life science companies are partnering with digital health players.
MM+M Podcast 1.11.22: Medical ad man David Chapman reflects
Ease into the New Year on an entertaining note as David Chapman looks back on an illustrious career in medical advertising.
Creating and selling work that reflects our diverse world
Kim Barke, SVP/creative director for the Bloc, and Lilian Galarraga, SVP/integrated strategy for CDM New York, talk about work their agencies have done that’s more reflective of the communities they serve. Fourth in our quarterly series spotlighting how firms from the membership of the Medical Advertising Hall of Fame are progressing along the DE&I journey.
J&J and the end of the consumer era
At the moment, owning a consumer company is not in fashion anymore among big pharma. Hear Steven Robins, managing partner/principal at the New England Consulting Group — and a former J&J exec — on what J&J’s recent decision to spin off its consumer group signals about corporate diversification as a business strategy in healthcare.
Mental illness in the medical marketing world
Industry leader Jon Nelson joins MM+M’s Larry Dobrow to discuss “I Am a Medical Marketing Professional Who Suffers From Mental Illness,” a column penned by Nelson that MM+M published this morning.
Better insights with real-world patient data
Bill Evans, chief marketing officer at Komodo Health, joins Steve Madden live from the floor of the HLTH conference to discuss how the company’s Healthcare Map is serving as a source for patient data.
The orphan drug launch, reconsidered
Charlie Gayer, chief commercial officer for BioCryst Pharmaceuticals, talks about how his company, which recently launched an oral medicine into a crowded category, used analytics to rethink the rare-disease drug launch.
The power of purpose
How Biolumina’s focus on oncology connects the personal with scientific progress.
MM+M Podcast 11.23.21: Nurx’s Varsha Rao
Rao, CEO of the company, joins Marc Iskowitz to talk about the evolution of the direct-to-consumer telemedicine space and Nurx’s expansion beyond its birth control roots.
Using proteomic tech to change the way disease is detected
Steve Williams, chief medical officer of SomaLogic, joined Steve Madden at HLTH, where they discussed the power of proteomics and its potential impact on health.
Appetite for Health Transformation: Verily & Highmark Health live from HLTH 2021
Dr. Vivian Lee, President Verily Health Platforms and David Holmberg, CEO, Highmark Health, take us on the journey of their shared vision from the HLTH 2021 conference.
The Healthtech Transformation is real
Dr. Geeta Nayyar joins Steve Madden live from the floor of the HLTH conference to discuss her passion in healthcare’s hybrid opportunities and the patient’s journey in healthtech’s digital revolution.
DE+I and the focus on women in the workplace
Ferring Pharmaceuticals’ Vice President, Operations, Shetal Vyas, joins Steve Madden live from the floor of the HLTH conference to discuss DE+I and women in the workplace.
The future of digital health, healthcare and pharma
We explore the growth of digital solutions for the provision of care and the impact they will have on patients, providers and life sciences companies.
MM+M Podcast 11.9.21: WOCIP’s Dr. Charlotte Jones-Burton
The president and co-founder of Women of Color in Pharma gives her take on a new clinical trial diversity initiative, and previews her group’s upcoming conference.
MM+M Podcast 11.2.21: RDA’s Michael Nace
Nace, brand director for Rare Disease Advisor (an MM+M sister brand), joins Marc Iskowitz to discuss trends shaping the awareness and commercialization of rare disease products.
MM+M Podcast 10.26.21: PulsePoint’s Maria Simeone
Simeone, VP of marketing at PulsePoint, joins Marc Iskowitz to explain findings from its half-year State of Health Media report.
MM+M Podcast 10.21.21: Issue One’s Danielle Caputo
Caputo, legislative and programs counsel for Washington watchdog group Issue One, talks about “dark money” and ethics in the advertising about Medicare drug-price negotiations.
MM+M Podcast 10.14.21: Highlights from the MM+M Awards dinner
MM+M’s Larry Dobrow and Marc Iskowitz recap highlights from the MM+M Awards, including interviews with some of the winners.
